Advertisement

Novo Integrated Sciences, Inc. NVOS

Set alert

Price alert · NVOS

All alert types
0.00 USD 0.00 +550.00%

At close · Oct 29

0.005 Day range 0.005
0.0001 52-week range 0.029
YTD
+44.44%
1 year
-22.00%
Open
0.005
Prev close
0.0006
Mkt cap
76.95K
Vol
1.51K
Avg vol
3.93K
EPS
-5.07
P/E
0.00
Div yield
0.00%
More statistics
Low
0.005
High
0.005
Forward P/E
0.00
Beta
-0.66
Short ratio
1.13
Inst. own
5.72%
Dividend
0.00
Ex-div date
50-d avg
0.18296
200-d avg
0.47943
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Dec 18, 2024Earnings: 0.31; estimate 0; surprise —%
Signals (122)
NameDateAgo
SMA: BullishOct 29, 20262 days ago
MACD: Buy SignalOct 29, 20262 days ago
MACD: Sell SignalOct 20, 20261 week ago
MACD: Buy SignalOct 16, 20262 weeks ago
SMA: BearishSep 30, 20261 month ago
MACD: Sell SignalSep 30, 20261 month ago
RSI: OversoldSep 30, 20261 month ago
SMA: BullishSep 3, 20261 month ago
SMA: BearishAug 31, 20262 months ago
SMA: BullishAug 27, 20262 months ago
MACD: Buy SignalAug 27, 20262 months ago
MACD: Sell SignalAug 12, 20262 months ago
MACD: Buy SignalJul 7, 20263 months ago
SMA: BearishJun 15, 20264 months ago
SMA: BearishJun 15, 20264 months ago
MACD: Sell SignalJun 8, 20264 months ago
SMA: BullishMay 27, 20265 months ago
SMA: BullishMay 27, 20265 months ago
MACD: Buy SignalMay 27, 20265 months ago
MACD: Sell SignalMay 20, 20265 months ago
SMA: BearishMay 19, 20265 months ago
SMA: BearishMay 19, 20265 months ago
SMA: BullishMay 14, 20265 months ago
SMA: BullishMay 14, 20265 months ago
MACD: Buy SignalMay 14, 20265 months ago
SMA: BearishMay 13, 20265 months ago
SMA: BearishMay 13, 20265 months ago
MACD: Sell SignalMay 13, 20265 months ago
SMA: BullishMay 12, 20265 months ago
SMA: BullishMay 12, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BullishMay 7, 20265 months ago
MACD: Buy SignalMay 7, 20265 months ago
RSI: OverboughtMay 7, 20265 months ago
MACD: Sell SignalApr 28, 20266 months ago
SMA: BearishApr 27, 20266 months ago
SMA: BullishApr 24, 20266 months ago
SMA: BearishApr 22, 20266 months ago
SMA: BullishApr 21, 20266 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BullishApr 17, 20266 months ago
SMA: BearishApr 16, 20266 months ago
SMA: BullishApr 10, 20266 months ago
SMA: BearishApr 9, 20266 months ago
SMA: BullishApr 8, 20266 months ago
MACD: Buy SignalApr 2, 20267 months ago
SMA: BullishApr 1, 20267 months ago
SMA: BearishMar 30, 20267 months ago
MACD: Sell SignalMar 30, 20267 months ago
MACD: Buy SignalMar 27, 20267 months ago
SMA: BullishMar 24, 20267 months ago
SMA: BearishMar 20, 20267 months ago
SMA: BearishMar 17, 20267 months ago
SMA: BullishMar 16, 20267 months ago
SMA: BullishMar 12, 20267 months ago
SMA: BearishMar 11, 20267 months ago
SMA: BearishMar 11, 20267 months ago
MACD: Sell SignalMar 11, 20267 months ago
SMA: BullishMar 10, 20267 months ago
MACD: Buy SignalMar 10, 20267 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BullishMar 6, 20267 months ago
MACD: Sell SignalFeb 27, 20268 months ago
MACD: Buy SignalFeb 6, 20268 months ago
SMA: BullishFeb 4, 20268 months ago
SMA: BearishJan 30, 20269 months ago
MACD: Sell SignalJan 30, 20269 months ago
SMA: BullishJan 16, 20269 months ago
MACD: Buy SignalDec 9, 202510 months ago
SMA: BearishNov 13, 202511 months ago
SMA: BullishNov 11, 202511 months ago
SMA: BearishNov 6, 202511 months ago
MACD: Sell SignalOct 23, 20251 year ago
SMA: BearishOct 20, 20251 year ago
SMA: BullishOct 17, 20251 year ago
RSI: OverboughtOct 17, 20251 year ago
MACD: Buy SignalOct 15, 20251 year ago
SMA: BullishOct 7, 20251 year ago
SMA: BearishOct 3, 20251 year ago
MACD: Sell SignalOct 3, 20251 year ago
SMA: BullishSep 19, 20251 year ago
MACD: Buy SignalSep 19, 20251 year ago
MACD: Sell SignalSep 18, 20251 year ago
SMA: BearishSep 17, 20251 year ago
RSI: OverboughtSep 16, 20251 year ago
SMA: BullishSep 4, 20251 year ago
MACD: Buy SignalAug 26, 20251 year ago
SMA: BearishAug 8, 20251 year ago
MACD: Sell SignalAug 8, 20251 year ago
SMA: BullishAug 1, 20251 year ago
MACD: Buy SignalJul 29, 20251 year ago
MACD: Sell SignalJul 28, 20251 year ago
SMA: BearishJul 15, 20251 year ago
SMA: BullishJul 14, 20251 year ago
MACD: Buy SignalJul 11, 20251 year ago
MACD: Sell SignalJul 3, 20251 year ago
MACD: Buy SignalJun 24, 20251 year ago
SMA: BearishJun 10, 20251 year ago
MACD: Sell SignalJun 10, 20251 year ago
SMA: BullishMay 29, 20251 year ago
SMA: BearishMay 20, 20251 year ago
SMA: BullishMay 16, 20251 year ago
RSI: OverboughtMay 16, 20251 year ago
MACD: Buy SignalApr 10, 20251 year ago
RSI: OversoldMar 21, 20251 year ago
MACD: Sell SignalMar 19, 20251 year ago
SMA: BearishMar 17, 20251 year ago
SMA: BullishMar 14, 20251 year ago
SMA: BearishMar 12, 20251 year ago
SMA: BullishMar 7, 20251 year ago
MACD: Buy SignalMar 7, 20251 year ago
SMA: BearishFeb 27, 20251 year ago
SMA: BullishFeb 26, 20251 year ago
SMA: BearishFeb 25, 20251 year ago
SMA: BullishFeb 24, 20251 year ago
SMA: BearishFeb 13, 20251 year ago
MACD: Sell SignalFeb 10, 20251 year ago
MACD: Buy SignalFeb 7, 20251 year ago
MACD: Sell SignalJan 23, 20251 year ago
RSI: OversoldDec 16, 20241 year ago
RSI: OversoldDec 10, 20241 year ago

Key statistics

Market cap
838.40K
Enterprise value
3.51M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.06
Price / book
0.08
EPS (TTM)
-1.33
Beta
-0.66
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-179.99%
Revenue (TTM)
13.52M
Revenue growth
-4.30%
Free cash flow
14.42M
Total cash
1.54M
Total debt
4.50M
Return on equity
-135.42%
Shares outstanding
19.05M
Short % of float
1.57%
50-day average
0.18296
200-day average
0.47943

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
NVOS Revenue — quarterly 3.15M
2020-Q4 20202021-Q1 20202021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20212022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 2024
NVOS Net income — quarterly -13.74M
2020-Q4 20202021-Q1 20202021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20212022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 2024
NVOS EPS — quarterly -0.74
2020-Q4 20202021-Q1 20202021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20212022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 2024

Earnings

NVOS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 18, 2024Aug 1, 20240.000.31——
Jul 19, 2024May 1, 20240.00-0.74——
Apr 15, 2024Feb 1, 20240.00-0.16——
Jul 17, 2023May 1, 20230.00-0.10——
May 26, 2023Feb 1, 20230.00-0.30——
May 24, 2023Nov 1, 20220.00-0.80——

About Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology services, such as telemedicine and remote patient monitoring; develops and distributes personalized health and wellness product solutions; and operates corporate-owned clinics. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States

News

Your note

Sign in to keep a note on NVOS — it syncs with the Stock Master app.

Institution ownership

NVOS institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc1.56%307,43513.53KSep 29, 2024
Blackrock Inc.1.47%290,45112.78KSep 29, 2024
Geode Capital Management, LLC0.75%148,1566.52KSep 29, 2024
HRT Financial LP0.47%93,5764.12KSep 29, 2024
UBS Group AG0.25%48,7522.15KSep 29, 2024
Virtu Financial LLC0.21%40,5351.78KSep 29, 2024

Fund ownership

NVOS fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund0.92%180,5597.94KJun 29, 2024
Vanguard Extended Market Index Fund0.83%163,7777.21KJun 29, 2024
Fidelity Extended Market Index Fund0.43%84,2903.71KSep 29, 2024
Fidelity Series Total Market Index Fund0.10%20,033881Sep 29, 2024
Fidelity Total Market Index Fund0.10%18,759825Sep 29, 2024
Fidelity NASDAQ Composite Index Fund0.05%10,097444Sep 29, 2024
Advertisement